JACKSONVILLE, Fla.--(BUSINESS WIRE)--Espero Pharmaceuticals, a specialty pharmaceutical company, assumed the U.S. promotional responsibility for Nitrolingual Pumpspray in an exclusive licensing agreement with G. Pohl-Boskamp GmbH&Co KG
![]()
↧
Espero Pharmaceuticals Announces Promotion of Nitrolingual® Pumpspray (nitroglycerin lingual spray)
↧